Literature DB >> 10710556

Guidelines on preventing cardiovascular disease in clinical practice.

R Jackson.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10710556      PMCID： PMC1117692          DOI： 10.1136/bmj.320.7236.659

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors:  E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal:  BMJ       Date:  2000-03-11

2.  Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

Authors:  S Ramachandran; J M French; M P Vanderpump; P Croft; R H Neary
Journal:  BMJ       Date:  2000-03-11

3.  Estimating cardiovascular risk for primary prevention: outstanding questions for primary care.

Authors:  J Robson; K Boomla; B Hart; G Feder
Journal:  BMJ       Date:  2000-03-11

4.  Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association.

Authors: 
Journal:  BMJ       Date:  2000-03-11

5.  Using the Framingham model to predict heart disease in the United Kingdom: retrospective study.

Authors:  S Ramachandran; J M French; M P Vanderpump; P Croft; R H Neary
Journal:  BMJ       Date:  2000-03-11

6.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

7.  Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial.

Authors:  A A Montgomery; T Fahey; T J Peters; C MacIntosh; D J Sharp
Journal:  BMJ       Date:  2000-03-11

8.  Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated.

Authors:  S Baker; P Priest; R Jackson
Journal:  BMJ       Date:  2000-03-11

Review 9.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

10.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05
View more
  33 in total

1.  National service framework's financial implications are huge.

Authors:  A S Wierzbicki; T M Reynolds
Journal:  BMJ       Date:  2000-09-16

2.  Statins: underused by those who would benefit.

Authors:  S B Hulley; D Grady; W S Browner
Journal:  BMJ       Date:  2000-10-21

3.  Paying for statins.

Authors:  Nick Raithatha; Richard D Smith
Journal:  BMJ       Date:  2004-02-14

4.  Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.

Authors:  Rodrigo M Carrillo-Larco; J Jaime Miranda; Xian Li; Chendi Cui; Xiaolin Xu; Mohammed Ali; Dewan S Alam; Thomas A Gaziano; Rajeev Gupta; Vilma Irazola; Naomi S Levitt; Dorairaj Prabhakaran; Adolfo Rubinstein; Krisela Steyn; Nikhil Tandon; Denis Xavier; Yangfeng Wu; Lijing L Yan
Journal:  Glob Heart       Date:  2016-03

Review 5.  Predicting melanoma risk: theory, practice and future challenges.

Authors:  David Whiteman
Journal:  Melanoma Manag       Date:  2014-12-04

6.  The Framingham Heart Study's impact on global risk assessment.

Authors:  Asaf Bitton; Thomas A Gaziano
Journal:  Prog Cardiovasc Dis       Date:  2010 Jul-Aug       Impact factor: 8.194

7.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Walter T Ambrosius; Kaycee M Sink; Capri G Foy; Dan R Berlowitz; Alfred K Cheung; William C Cushman; Lawrence J Fine; David C Goff; Karen C Johnson; Anthony A Killeen; Cora E Lewis; Suzanne Oparil; David M Reboussin; Michael V Rocco; Joni K Snyder; Jeff D Williamson; Jackson T Wright; Paul K Whelton
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

8.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

Authors:  B Balkau; G Hu; Q Qiao; J Tuomilehto; K Borch-Johnsen; K Pyörälä
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

9.  The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.

Authors:  Peter M Brindle; Alex McConnachie; Mark N Upton; Carole L Hart; George Davey Smith; Graham C M Watt
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386

10.  Modifiable risk factors predicting major depressive disorder at four year follow-up: a decision tree approach.

Authors:  Philip J Batterham; Helen Christensen; Andrew J Mackinnon
Journal:  BMC Psychiatry       Date:  2009-11-22       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.